VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of the combination of Velcade
and Rituximab in patients with relapsed Non Hodgkin's Follicular Lymphoma.